Sec. 17744f.
(1) Subject to subsection (2), a pharmacist may dispense an emergency supply of insulin to an individual if the individual has a qualified prescription for insulin in the individual's name with no remaining authorized refills, the individual has previously had a prescription for insulin dispensed at the pharmacy, and, in the pharmacist's professional judgment, a failure to dispense the emergency supply of insulin might interrupt the individual's ongoing care and have a significant adverse effect on the individual's well-being. A pharmacist who dispenses an emergency supply of insulin under this section shall comply with all of the following:
(a) Before dispensing the emergency supply of insulin, make a reasonable effort to communicate with the prescriber who issued the qualified prescription for insulin regarding dispensing the emergency supply of insulin and document the efforts made.
(b) Document all of the following:
(i) The name of the individual receiving the emergency supply of insulin and the date of the dispensing.
(ii) The reason for dispensing the emergency supply of insulin.
(iii) Evidence of the individual's qualified prescription for insulin.
(iv) Information on the individual's diabetes management.
(v) Any other information required by the board by rule.
(c) Within 5 business days after dispensing the emergency supply of insulin, inform the prescriber who issued the qualified prescription for insulin, in writing, that an emergency supply of insulin was dispensed under this section.
(d) Inform the individual receiving the emergency supply of insulin that the insulin was dispensed under this section.
(2) An individual shall not receive more than 3 emergency supplies of insulin under this section in 1 calendar year. After an emergency supply of insulin is dispensed to an individual under this section, a pharmacist shall not dispense a subsequent emergency supply of insulin under this section within the same calendar year to that individual unless the individual has since obtained a new qualified prescription for insulin with no remaining authorized refills.
(3) A prescriber or pharmacist is not subject to criminal prosecution, civil liability, or administrative sanction as a result of the pharmacist dispensing an emergency supply of insulin under this section.
(4) The board shall promulgate rules to implement this section.
(5) As used in this section:
(a) "Emergency supply" means up to a 30-day supply.
(b) "Qualified prescription for insulin" means a prescription for insulin that was issued within the 12-month period immediately preceding the date the individual requests an emergency supply of insulin under this section.
History: Add. 2021, Act 36, Imd. Eff. July 1, 2021 Popular Name: Act 368
Structure Michigan Compiled Laws
Act 368 of 1978 - Public Health Code (333.1101 - 333.25211)
Article 15 - Occupations (333.16101...333.18838)
368-1978-15-177 - Part 177 Pharmacy Practice and Drug Control (333.17701...333.17780)
Section 333.17702 - Definitions; a to C.
Section 333.17703 - Definitions; D, E.
Section 333.17704 - Definitions; F to I.
Section 333.17705 - Definitions; L.
Section 333.17706 - Definitions; M, O.
Section 333.17707 - Definitions; P.
Section 333.17708 - Definitions; P to R.
Section 333.17709 - Definitions; S to W.
Section 333.17721 - Michigan Board of Pharmacy; Creation; Membership; Terms.
Section 333.17722 - Michigan Board of Pharmacy; Duties Generally.
Section 333.17726 - Certificate of Licensure; Issuance.
Section 333.17733 - Relicensure of Pharmacist; Requirements.
Section 333.17737 - Rules Establishing Standards for Internship Program; Limited License Required.
Section 333.17739 - Pharmacy Technician; Functions; Licensure.
Section 333.17739b - Pharmacy Technician; Temporary License.
Section 333.17739c - Pharmacy Technician; Limited License.
Section 333.17742 - Disclosure; "Applicant" Defined.
Section 333.17742a - Remote Pharmacy; Operation; Licensure Requirements; Location Waiver; Exception.
Section 333.17743 - Pharmacy License; Contents; Duration.
Section 333.17744a - Auto-Injectable Epinephrine; Prescribing or Issuing to Authorizing Entity.
Section 333.17744b - Prescribing, Possessing, or Dispensing Opioid Antagonist; Liability.
Section 333.17748c - Compounding Pharmaceutical; Commercial Availability.
Section 333.17748d - Violation of MCL 333.17748a or 17748b; Penality.
Section 333.17750a - Dispensing of Prescription for Therapeutic Pharmaceutical Agent by Pharmacist.
Section 333.17756 - Label on Prescription; Contents.
Section 333.17757b - Contracts With Pharmacy Benefit Managers; Prohibited Terms.
Section 333.17758 - Repealed. 1986, Act 304, Eff. Mar. 31, 1987.
Section 333.17759 - Dispensing Harmful Drug; Requirements.
Section 333.17761 - Display of Notice; Dispensing Prescription in Safety Closure Container.
Section 333.17762 - Misbranded Prescription.
Section 333.17764 - Conduct Constituting Misdemeanor; Violation; Penalty; Other Violations.
Section 333.17766 - Additional Conduct Constituting Misdemeanor.
Section 333.17766a - Repealed. 2001, Act 236, Imd. Eff. Jan. 3, 2002.
Section 333.17766b - Repealed. 2001, Act 231, Eff. Jan. 6, 2003.
Section 333.17767 - Rules and Determinations as to Licensing.
Section 333.17770 - Exceptions.
Section 333.17776 - Destruction and Disposal of Certain Drugs and Medications.